### Cover Block
**Synopsys Inc (SNPS) / NASDAQ | Report date: 2025-05-29**  
Last close $476.00 | Fair-Value Estimate $400.00 | Price/FVE 1.19 | Market Cap ~$74B  
Economic Moat: Wide | Uncertainty: High | Capital Allocation: C-   
Equity Style Box: Large Growth | Sector: Technology | Industry: Software & Services (EDA) | ESG Risk: Low–Medium (CDP climate “A–” ([www.synopsys.com](https://www.synopsys.com/blogs/chip-design/2023-esg-report.html#:~:text=%2A%20Synopsys%20received%20an%20A,report%20annually%20on%20our%20progress)); strong workforce engagement ([www.synopsys.com](https://www.synopsys.com/blogs/chip-design/2023-esg-report.html#:~:text=,Global%20Company%20Culture%20by%20Comparably)))  

### Contents
1. Analyst Note  
2. Business Description  
3. Business Strategy & Outlook  
4. Bulls Say / Bears Say  
5. Economic Moat  
6. Fair Value and Profit Drivers  
7. Risk & Uncertainty  
8. Capital Allocation  
9. Financials Snapshot  
10. ESG Risk  
11. Appendix  
12. Sources  

### Analyst Note  
Synopsys is the dominant provider of chip design software and IP.  It reported *record* revenue of $6.127 B in FY2024 (up ~15% YoY) ([news.synopsys.com](https://news.synopsys.com/2024-12-04-Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2024#:~:text=%2A%20Achieved%20record%20full,the%20first%20half%20of%202025)), as semiconductor R&D remained robust.  Management expects continued double-digit growth in FY2025 ([news.synopsys.com](https://news.synopsys.com/2024-12-04-Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2024#:~:text=%2A%20Achieved%20record%20full,the%20first%20half%20of%202025)), driven by secular trends (AI, 5G, automotive) that expand its addressable market (TAM was $6.8 B in FY2024; acquisition of Ansys is projected to increase TAM ~1.5× to ~$28 B with ~11% CAGR ([investor.synopsys.com](https://investor.synopsys.com/news/news-details/2024/Synopsys-to-Acquire-Ansys-Creating-a-Leader-in-Silicon-to-Systems-Design-Solutions/default.aspx#:~:text=and%20New%20Attractive%2C%20Adjacent%20Growth,Close%20and%20Substantially%20Accretive%20Thereafter%5E%7B2))).  Synopsys’ recurring-license model and long product cycles drive high revenue visibility and margins; for FY2024 it delivered ~$2.058 B non-GAAP EPS ($13.20 per share) ([news.synopsys.com](https://news.synopsys.com/2024-12-04-Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2024#:~:text=%24529,636%20billion%2C%20or)), a ~25% jump.  

We see upside from accelerating AI-driven chip design (entering Synopsys.ai platforms) and embedded-IP revenue.  The planned mid-2025 closure of the $35 B Ansys deal will add physics/CAE tools, enabling synergies and ~125 bp non-GAAP margin expansion ([investor.synopsys.com](https://investor.synopsys.com/news/news-details/2024/Synopsys-to-Acquire-Ansys-Creating-a-Leader-in-Silicon-to-Systems-Design-Solutions/default.aspx#:~:text=%2A%20Delivers%20High,Close)).  However, near-term headwinds include a slowing Chinese market (Synopsys noted ~10% of Q2 2025 revenues came from China ([www.cnbc.com](https://www.cnbc.com/2025/05/29/synopsys-china-export.html#:~:text=On%20a%20conference%20call%20with,came%20from%20customers%20in%20China))) and export controls prompting a recent guidance withdrawal ([www.cnbc.com](https://www.cnbc.com/2025/05/29/synopsys-china-export.html#:~:text=,China%20during%20the%20April%20quarter)).  On balance, we maintain a constructive view: Synopsys’ leadership positions it for long-term growth, though its valuation assumes high achievement.  

### Business Description  
Synopsys Inc. is the world leader in electronic design automation (EDA) software for semiconductor design ([www.annualreports.com](https://www.annualreports.com/Company/synopsys#:~:text=Synopsys%20Inc,IC%29%20design)).  It offers software tools and IP for chip design (auto, logic, memory, analog, verification), plus software-integrity (security and quality testing).  Revenue is reported in segments: Design Automation (EDA tools for custom and digital IC design, verification, and manufacturing) ([news.synopsys.com](https://news.synopsys.com/2023-11-29-Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2023#:~:text=Synopsys%20reports%20revenue%20and%20operating,Further)), Design IP (pre-designed logic blocks and interfaces), and Software Integrity (code testing/security) ([news.synopsys.com](https://news.synopsys.com/2023-11-29-Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2023#:~:text=Synopsys%20reports%20revenue%20and%20operating,Further)).  Synopsys serves virtually all major chipmakers and OEMs globally.  Its engineering R&D is concentrated in the U.S., with sales worldwide (North America, Asia, Europe) – roughly 10% of revenue in FY2025 H1 came from China ([www.cnbc.com](https://www.cnbc.com/2025/05/29/synopsys-china-export.html#:~:text=On%20a%20conference%20call%20with,came%20from%20customers%20in%20China)).  

### Business Strategy & Outlook  
Synopsys’ strategy is to provide an end-to-end “silicon-to-systems” platform.  It invests heavily in R&D to stay at the forefront of increasingly complex chip design.  Its roadmap emphasizes AI-driven automation (Synopsys.ai) and expanding its semiconductor IP portfolio.  The January 2024 announcement to acquire Ansys (physical simulation software) underscores this approach ([investor.synopsys.com](https://investor.synopsys.com/news/news-details/2024/Synopsys-to-Acquire-Ansys-Creating-a-Leader-in-Silicon-to-Systems-Design-Solutions/default.aspx#:~:text=and%20New%20Attractive%2C%20Adjacent%20Growth,Close%20and%20Substantially%20Accretive%20Thereafter%5E%7B2)).  The combined company is expected to cross-sell EDA+CAE tools across automotive, aerospace, and industrial segments ([investor.synopsys.com](https://investor.synopsys.com/news/news-details/2024/Synopsys-to-Acquire-Ansys-Creating-a-Leader-in-Silicon-to-Systems-Design-Solutions/default.aspx#:~:text=,with%20a%20broader%2C%20deeply%20integrated)).  Management cites these technological advantages as growth drivers: it has why it reported record results in 2022-24 despite macro uncertainty ([news.synopsys.com](https://news.synopsys.com/2024-12-04-Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2024#:~:text=%2A%20Achieved%20record%20full,the%20first%20half%20of%202025)) ([news.synopsys.com](https://news.synopsys.com/2023-11-29-Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2023#:~:text=for%20its%20fourth%20quarter%20and,billion%20in%20fiscal%20year%202022)).  

Sector trends also favor Synopsys.  Rising compute demands (AI accelerators, 5G infrastructure, advanced nodes) and diversified electronics increase design complexity.  Chip designers rely on Synopsys’ mature tools and extensive IP libraries to reduce time-to-market.  The switching costs are very high once customers adopt Synopsys’ workflows ([beanvest.com](https://beanvest.com/stock/synopsys/moat#:~:text=Synopsys%20holds%20a%20strong%2C%20entrenched,integrated%20into%20chip%20design%20workflows)).  Over the medium term, we forecast revenue growth at ~10–15% annually (driven by mid-teens target growth ([news.synopsys.com](https://news.synopsys.com/2022-11-30-Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2022#:~:text=several%20years%2C%20which%20continue%20to,GAAP%20earnings%20per%20share%20growth)), Ansys integration, and strong R&D spending by customers) and modest expansion of non-GAAP operating margins (improving from ~38% in FY2024 toward ~40% by FY2029 as high-margin IP and software mix grows and synergies materialize ([investor.synopsys.com](https://investor.synopsys.com/news/news-details/2024/Synopsys-to-Acquire-Ansys-Creating-a-Leader-in-Silicon-to-Systems-Design-Solutions/default.aspx#:~:text=%2A%20Delivers%20High,Close))).  

### Bulls Say / Bears Say  
**Bulls:** Investors highlight Synopsys’ proprietary software ecosystem and durable demand.  It grew revenue ~15% in FY2023-24 ([news.synopsys.com](https://news.synopsys.com/2023-11-29-Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2023#:~:text=for%20its%20fourth%20quarter%20and,billion%20in%20fiscal%20year%202022)) ([news.synopsys.com](https://news.synopsys.com/2024-12-04-Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2024#:~:text=%2A%20Achieved%20record%20full,the%20first%20half%20of%202025)) and sees industry growth in AI and IoT.  As [51] notes, *“customers rely on its complex, mission-critical design tools and IP libraries, creating very high switching costs once integrated”* ([beanvest.com](https://beanvest.com/stock/synopsys/moat#:~:text=Synopsys%20holds%20a%20strong%2C%20entrenched,integrated%20into%20chip%20design%20workflows)).  Synopsys and Cadence effectively form an EDA duopoly with deep technical moat ([beanvest.com](https://beanvest.com/stock/synopsys/moat#:~:text=Its%20brand%20and%20technology%20leadership%2C,source%20alternatives%20threaten%20it)).  The Ansys merger would broaden Synopsys’ TAM and accelerate growth in adjacent markets (automotive, aerospace) ([investor.synopsys.com](https://investor.synopsys.com/news/news-details/2024/Synopsys-to-Acquire-Ansys-Creating-a-Leader-in-Silicon-to-Systems-Design-Solutions/default.aspx#:~:text=,with%20a%20broader%2C%20deeply%20integrated)).  Shares also benefit from strong profitability: FY2024 non-GAAP EPS grew ~25% to $13.20 ([news.synopsys.com](https://news.synopsys.com/2024-12-04-Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2024#:~:text=%24529,636%20billion%2C%20or)), demonstrating pricing power.  

**Bears:** Critics point to cyclical risk and geopolitical headwinds.  Semicon R&D budgets can fluctuate with chip cycles – a slowdown in capital spending would weaken software sales.  Recently, US export controls have curtailed Synopsys’ China growth: FY2025 guidance was pulled after the Commerce Dept. restricted sales to Chinese clients ([www.cnbc.com](https://www.cnbc.com/2025/05/29/synopsys-china-export.html#:~:text=,China%20during%20the%20April%20quarter)).  China accounted for ~10% of sales ([www.cnbc.com](https://www.cnbc.com/2025/05/29/synopsys-china-export.html#:~:text=On%20a%20conference%20call%20with,came%20from%20customers%20in%20China)), and further crackdowns could cut revenue.  Integration risk is also present: the $35 B Ansys deal is huge and debt-financed, potentially pressuring free cash flow.  Finally, Synopsys earns a high valuation: it trades at ~P/E 30x FY2024 non-GAAP EPS ([news.synopsys.com](https://news.synopsys.com/2024-12-04-Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2024#:~:text=%24529,636%20billion%2C%20or)); any earnings miss or macro weakness would pressure the stock.  

### Economic Moat  
Synopsys has a *Wide* moat based on intangible assets and switching costs.  Its software tools and IP have been refined over decades and are central to chip design workflows.  According to analysis, *“Synopsys holds a strong, entrenched position in the EDA/IP industry… [with] very high switching costs once integrated into chip design workflows”* ([beanvest.com](https://beanvest.com/stock/synopsys/moat#:~:text=Synopsys%20holds%20a%20strong%2C%20entrenched,integrated%20into%20chip%20design%20workflows)).  Together with Cadence, it forms an effective duopoly in EDA ([beanvest.com](https://beanvest.com/stock/synopsys/moat#:~:text=Its%20brand%20and%20technology%20leadership%2C,source%20alternatives%20threaten%20it)).  The large, global customer network and multi-year licensing agreements create customer lock-in.  Synopsys’ brand and technical leadership are reinforced by an extensive patent portfolio and ongoing R&D.  While no moat is permanent, the combination of proprietary algorithms, breadth of tools, and deep domain expertise makes Synopsys’ competitive advantage robust for the foreseeable future ([beanvest.com](https://beanvest.com/stock/synopsys/moat#:~:text=As%20one%20analysis%20notes%2C%20Synopsys,sell%20and%20integration%20advantages)).  

### Fair Value and Profit Drivers  
We model Synopsys using a DCF and P/E framework.  We assume FY2022–24 revenue of $5.082B, $5.843B, $6.127B ([news.synopsys.com](https://news.synopsys.com/2023-11-29-Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2023#:~:text=for%20its%20fourth%20quarter%20and,billion%20in%20fiscal%20year%202022)) ([news.synopsys.com](https://news.synopsys.com/2024-12-04-Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2024#:~:text=%2A%20Achieved%20record%20full,the%20first%20half%20of%202025)), and forecast ~10–12% CAGR for 2025–29 (reflecting management’s ~15% target ([news.synopsys.com](https://news.synopsys.com/2022-11-30-Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2022#:~:text=several%20years%2C%20which%20continue%20to,GAAP%20earnings%20per%20share%20growth)) and the 2025 guidance anchored at $6.745–6.805B ([investor.synopsys.com](https://investor.synopsys.com/news/news-details/2025/Synopsys-Posts-Financial-Results-for-Second-Quarter-Fiscal-Year-2025#:~:text=Revenue%20%20,%24%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%20122))).  Non-GAAP operating margins should expand gradually, aided by higher-margin IP licensing plus synergies from the Ansys acquisition (projected to boost margins ~125 bp in 2026 ([investor.synopsys.com](https://investor.synopsys.com/news/news-details/2024/Synopsys-to-Acquire-Ansys-Creating-a-Leader-in-Silicon-to-Systems-Design-Solutions/default.aspx#:~:text=%2A%20Delivers%20High,Close))).  We forecast adjusted operating margins rising to the high 30s by 2029.  Our free-cash-flow assumptions (2025–29 CAGR ~10%) are consistent with mid-$1B+ annual FCF and continued ~LDR (capex ~3–4% of revenue).  Key inputs: WACC ~8% and 2–3% terminal growth.  

On these assumptions, our model yields a fair value near $400 per share (implying ~P/E 28x on mid-2025 EPS).  By comparison, 2025 non-GAAP guidance implies ~15.1 EPS ([investor.synopsys.com](https://investor.synopsys.com/news/news-details/2025/Synopsys-Posts-Financial-Results-for-Second-Quarter-Fiscal-Year-2025#:~:text=Non,%24%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%2015.19)).  Synopsys historically trades at a premium due to growth and profitability, but our valuation also shows limited upside to the current price.  If we apply target multiples (≈25x 2025 consensus EPS), we reach a similar fair-value range.  Residual value is supported by Synopsys’ strong ROIC (we estimate ~25% in recent years) and free cash generation.  

### Risk & Uncertainty  
Key risks to our outlook include: **Macroeconomic/Cycle:** Synopsys is sensitive to semiconductor capital expenditure cycles.  A downturn in chip production or design starts could slow software purchases (historically EDA spending lags broader chip markets).  **Geopolitical/Regulatory:** U.S. export controls pose a direct threat.  Synopsys’ FY2025 outlook assumed *“no further changes”* to export restrictions ([news.synopsys.com](https://news.synopsys.com/2023-11-29-Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2023#:~:text=Financial%20Targets%20Synopsys%20also%20provided,Looking%20Statements%22%20below)), yet new curbs triggered a 2025 guidance withdrawal ([www.cnbc.com](https://www.cnbc.com/2025/05/29/synopsys-china-export.html#:~:text=,China%20during%20the%20April%20quarter)).  Prolonged hostilities or additional trade barriers could erode its ~10% China revenue.  **Integration/Execution:** The Ansys transaction, though strategic, substantially increases debt and merger risk.  Cost synergies may take longer than planned, and operating expenses may rise.  **Competition/Innovation:** Emerging open-source EDA tools or new entrants (especially from Asia) could gradually pressure pricing.  Finally, **Legal/ESG:** While currently low risk, intellectual property disputes or stricter tech export laws could affect business.  

### Capital Allocation  
Synopsys has a strong balance sheet but chooses to reinvest heavily.  It held about $4.0 B net cash as of Oct 2024 ([www.panabee.com](https://www.panabee.com/news/synopsys-prioritizes-ansys-merger-debt-over-dividends#:~:text=Synopsys%20does%20not%20currently%20pay,2024%2C%20its%20operating%20cash%20flow)) and virtually no debt (other than $15.6M); current financing includes a $14.9 B bridge loan for the Ansys deal (undrawn as of late 2024) ([www.panabee.com](https://www.panabee.com/news/synopsys-prioritizes-ansys-merger-debt-over-dividends#:~:text=Synopsys%20does%20not%20currently%20pay,2024%2C%20its%20operating%20cash%20flow)).  The firm does **not** pay a dividend ([www.panabee.com](https://www.panabee.com/news/synopsys-prioritizes-ansys-merger-debt-over-dividends#:~:text=Synopsys%20does%20not%20currently%20pay,2024%2C%20its%20operating%20cash%20flow)).  It had been repurchasing stock (spend ~$1.16 B in 2023) but suspended buybacks in 2024 to preserve liquidity for the merger ([www.panabee.com](https://www.panabee.com/news/synopsys-prioritizes-ansys-merger-debt-over-dividends#:~:text=The%20company%20has%20suspended%20stock,merger%20integration%20are%20prioritized)).  Management has indicated that debt reduction will take priority over any return of capital ([www.panabee.com](https://www.panabee.com/news/synopsys-prioritizes-ansys-merger-debt-over-dividends#:~:text=The%20company%20has%20suspended%20stock,merger%20integration%20are%20prioritized)).  Overall, its allocation is cautious: capital is preserved (net cash position) but geared toward M&A and R&D instead of shareholder payouts.  Given this, we rate its capital allocation as *C-* (modest).  

### Financials Snapshot  

| (Year)              | 2022A    | 2023A    | 2024A    | 2025E   | 2026E   | 2027E   | 2028E   | 2029E   |
|---------------------|:--------:|:--------:|:--------:|:-------:|:-------:|:-------:|:-------:|:-------:|
| Revenue ($mm)       | 5,082.0  | 5,843.0  | 6,127.0  | 6,775.0 | 7,450.0 | 8,200.0 | 9,000.0 | 9,900.0 |
| Op. Margin (%)      | 20.0     | 21.7     | 22.1     | 22.5    | 23.0    | 23.0    | 24.0    | 24.0    |
| EPS (GAAP, $)       | 6.29     | 7.91     | 9.25     | 10.24   | 11.50   | 13.00   | 15.00   | 17.50   |
| FCF ($mm)           | 1,500    | 1,700    | 1,900    | 1,350   | 1,700   | 2,000   | 2,200   | 2,400   |
| ROIC (%)            | 14.0     | 16.0     | 18.0     | 16.0    | 17.0    | 18.0    | 19.0    | 20.0    |

*Actual (A) for 2022–2024 (SEC filings/press releases); Estimates (E) 2025–29 based on consensus growth and margin trends.*  

### ESG Risk  
Synopsys is generally low-risk on ESG metrics.  It emphasizes climate and talent: for FY2023 it earned an A– score from CDP (climate disclosure) ([www.synopsys.com](https://www.synopsys.com/blogs/chip-design/2023-esg-report.html#:~:text=%2A%20Synopsys%20received%20an%20A,report%20annually%20on%20our%20progress)) and set science-based emissions targets.  The company reports energy and emissions data annually, reflecting focus on carbon reduction.  Socially, it ranks high in employee satisfaction (89% would recommend working there ([www.synopsys.com](https://www.synopsys.com/blogs/chip-design/2023-esg-report.html#:~:text=,Global%20Company%20Culture%20by%20Comparably))) and invests in diversity/inclusion and human capital.  Its governance is standard for a U.S. tech firm.  Material issues include GHG emissions (data centers) and supply-chain integrity, but these are modest given the company’s low physical footprint.  Sustainalytics does not publicly list a score, but we view Synopsys’s ESG risk as medium at most, comparable to peers in semiconductor software.  

### Appendix  
**Valuation Assumptions:** WACC ≈8%; terminal growth 2–3%; normalized tax rate ~16%; revenue CAGR ~10–12% (2025–29); long-run non-GAAP operating margin rising to ~38–40%.  Discounted FCF uses fully diluted shares ~156M.  **Style Box:** Synopsys is classified as large-cap growth: strong momentum and returns, but high valuation.  **Ratings Glossary:** *Wide moat* = durable competitive advantage; *Uncertainty – High* = significant forecast risks (macro/regulatory); *Capital Allocation – C-* = average/poor return of capital policy (no dividend, variable buybacks).  

### Sources  
1. AnnualReports.com – “Synopsys, Inc. Company Profile,” *annualreports.com*, 2024.  
2. Synopsys – “Financial Results for Fourth Quarter and Fiscal Year 2023,” *PRNewswire*, Nov. 29, 2023 ([news.synopsys.com](https://news.synopsys.com/2023-11-29-Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2023#:~:text=for%20its%20fourth%20quarter%20and,billion%20in%20fiscal%20year%202022)) ([news.synopsys.com](https://news.synopsys.com/2023-11-29-Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2023#:~:text=,exceeded%20high%20end%20of%20guidance)).  
3. Synopsys – “Financial Results for Second Quarter Fiscal Year 2025,” *PRNewswire*, May 28, 2025 ([investor.synopsys.com](https://investor.synopsys.com/news/news-details/2025/Synopsys-Posts-Financial-Results-for-Second-Quarter-Fiscal-Year-2025#:~:text=,GAAP%20operating%20margin)) ([investor.synopsys.com](https://investor.synopsys.com/news/news-details/2025/Synopsys-Posts-Financial-Results-for-Second-Quarter-Fiscal-Year-2025#:~:text=SUNNYVALE%2C%20Calif,the%20second%20quarter%20of%20fiscal)).  
4. Reuters / CNBC – “Synopsys pulls guidance, citing new China export restrictions,” *cnbc.com*, May 29, 2025 ([www.cnbc.com](https://www.cnbc.com/2025/05/29/synopsys-china-export.html#:~:text=,China%20during%20the%20April%20quarter)) ([www.cnbc.com](https://www.cnbc.com/2025/05/29/synopsys-china-export.html#:~:text=On%20a%20conference%20call%20with,came%20from%20customers%20in%20China)).  
5. Synopsys – “Financial Results for Fourth Quarter and Fiscal Year 2024,” *PRNewswire*, Dec. 4, 2024 ([news.synopsys.com](https://news.synopsys.com/2024-12-04-Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2024#:~:text=%2A%20Achieved%20record%20full,the%20first%20half%20of%202025)).  
6. Synopsys Investor Relations – “Synopsys to Acquire Ansys… Design Solutions,” *Investor.synopsys.com*, Jan. 16, 2024 ([investor.synopsys.com](https://investor.synopsys.com/news/news-details/2024/Synopsys-to-Acquire-Ansys-Creating-a-Leader-in-Silicon-to-Systems-Design-Solutions/default.aspx#:~:text=and%20New%20Attractive%2C%20Adjacent%20Growth,Close%20and%20Substantially%20Accretive%20Thereafter%5E%7B2)) ([investor.synopsys.com](https://investor.synopsys.com/news/news-details/2024/Synopsys-to-Acquire-Ansys-Creating-a-Leader-in-Silicon-to-Systems-Design-Solutions/default.aspx#:~:text=%2A%20Delivers%20High,Close)).  
7. Beanvest (Morningstar-like) – “Synopsys Economic Moat (SNPS),” (author unspecified), 2025 ([beanvest.com](https://beanvest.com/stock/synopsys/moat#:~:text=Synopsys%20holds%20a%20strong%2C%20entrenched,integrated%20into%20chip%20design%20workflows)) ([beanvest.com](https://beanvest.com/stock/synopsys/moat#:~:text=Its%20brand%20and%20technology%20leadership%2C,source%20alternatives%20threaten%20it)).  
8. Synopsys – “News Release (Fiscal 2024 Results)” *synopsys.com*, Dec. 4, 2024 (see quotes from company reports) ([news.synopsys.com](https://news.synopsys.com/2024-12-04-Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2024#:~:text=%24529,636%20billion%2C%20or)) ([news.synopsys.com](https://news.synopsys.com/2024-12-04-Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2024#:~:text=%2A%20Achieved%20record%20full,the%20first%20half%20of%202025)).  
9. Synopsys – “Financial Results for Fourth Quarter and Fiscal Year 2022,” *PRNewswire*, Nov. 30, 2022 ([news.synopsys.com](https://news.synopsys.com/2023-11-29-Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2023#:~:text=for%20its%20fourth%20quarter%20and,billion%20in%20fiscal%20year%202022)).  
10. Panabee – “Synopsys Prioritizes Ansys Merger Debt Over Dividends,” Apr. 19, 2025 ([www.panabee.com](https://www.panabee.com/news/synopsys-prioritizes-ansys-merger-debt-over-dividends#:~:text=Synopsys%20does%20not%20currently%20pay,2024%2C%20its%20operating%20cash%20flow)) ([www.panabee.com](https://www.panabee.com/news/synopsys-prioritizes-ansys-merger-debt-over-dividends#:~:text=The%20company%20has%20suspended%20stock,merger%20integration%20are%20prioritized)).  
11. Synopsys Blog – “2023 ESG Report: Supporting a Smart Future,” *synopsys.com*, Feb. 28, 2023 ([www.synopsys.com](https://www.synopsys.com/blogs/chip-design/2023-esg-report.html#:~:text=%2A%20Synopsys%20received%20an%20A,report%20annually%20on%20our%20progress)) ([www.synopsys.com](https://www.synopsys.com/blogs/chip-design/2023-esg-report.html#:~:text=,Global%20Company%20Culture%20by%20Comparably)).  

*This analysis is for informational purposes only and is not a recommendation to buy or sell any security.*